Voyager Therapeutics Company Profile (NASDAQ:VYGR)

About Voyager Therapeutics

Voyager Therapeutics logoVoyager Therapeutics, Inc. is a clinical-stage gene therapy company. The Company is focused on developing life-changing treatments for patients suffering from severe diseases of the central nervous system (CNS). The Company's product pipeline includes programs for Parkinson's disease, a monogenic form of amyotrophic lateral sclerosis (ALS), Friedreich's ataxia, Huntington's disease, spinal muscular atrophy (SMA), frontotemporal dementia, Alzheimer's disease and severe, chronic pain. Its products include VY-AADC01 for Advanced Parkinson's Disease, VY-SOD101 for Monogenic amyotrophic lateral sclerosis (ALS), VY-FXN01 for Friedreich's Ataxia, VY-HTT01 for Huntington's Disease and VY-SMN101 for spinal muscular atrophy (SMA). VY-AADC01 consists of the AAV2 capsid, which has been used in multiple adeno-associated virus (AAV) gene therapy clinical trials for various diseases, and the cytomegalovirus promoter that drives expression of the AADC transgene.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: VYGR
  • CUSIP:
Key Metrics:
  • Previous Close: $13.89
  • 50 Day Moving Average: $14.02
  • 200 Day Moving Average: $12.45
  • 52-Week Range: $26,728,000.00 - $8.12
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.53
  • P/E Growth: 0.00
  • Market Cap: $370.18M
  • Outstanding Shares: 26,728,000
Profitability:
  • Net Margins: -150.47%
  • Return on Equity: -25.13%
  • Return on Assets: -13.43%
Debt:
  • Current Ratio: 10.40%
  • Quick Ratio: 10.40%
Additional Links:
Companies Related to Voyager Therapeutics:

Analyst Ratings

Consensus Ratings for Voyager Therapeutics (NASDAQ:VYGR) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $30.25 (118.41% upside)

Analysts' Ratings History for Voyager Therapeutics (NASDAQ:VYGR)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016WedbushReiterated RatingOutperform$36.00View Rating Details
8/11/2016Piper Jaffray Cos.Set Price TargetBuy$37.00View Rating Details
7/14/2016Stifel NicolausInitiated CoverageBuy -> Buy$33.00View Rating Details
6/22/2016Cowen and CompanyReiterated RatingBuyView Rating Details
5/20/2016Wells Fargo & Co.Initiated CoverageOutperformView Rating Details
1/25/2016Chardan CapitalUpgradeSell -> Neutral$20.00 -> $15.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Voyager Therapeutics (NASDAQ:VYGR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/15/2016        
8/11/2016Q2($0.34)($0.37)ViewListenView Earnings Details
5/12/2016Q1($0.38)$0.29ViewListenView Earnings Details
3/17/2016Q4($0.55)($0.67)$4.94 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Voyager Therapeutics (NASDAQ:VYGR)
Current Year EPS Consensus Estimate: $-1.53 EPS
Next Year EPS Consensus Estimate: $-1.84 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.38)($0.38)($0.38)
Q4 20161($0.42)($0.42)($0.42)
Q1 20171($0.44)($0.44)($0.44)
Q2 20171($0.45)($0.45)($0.45)
Q3 20171($0.47)($0.47)($0.47)
Q4 20171($0.49)($0.49)($0.49)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Voyager Therapeutics (NASDAQ:VYGR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Voyager Therapeutics (NASDAQ:VYGR)
Insider Ownership Percentage: 6.00%
Institutional Ownership Percentage: 39.66%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/14/2016Steven M PaulCEOBuy10,000$14.07$140,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Voyager Therapeutics (NASDAQ:VYGR)
DateHeadline
publicnow.com logoVoyager Therapeutics Licenses Novel Gene Therapy Capsids from the California Institute of Technology (NASDAQ:VYGR)
www.publicnow.com - September 15 at 11:48 AM
capitalcube.com logoVoyager Therapeutics, Inc. – Value Analysis (NASDAQ:VYGR) : September 14, 2016 (NASDAQ:VYGR)
www.capitalcube.com - September 14 at 8:15 PM
nasdaq.com logoThe News From Voyager Therapeutics (VYGR) May Be More Significant Than Many Think (NASDAQ:VYGR)
www.nasdaq.com - September 14 at 12:25 PM
capitalcube.com logoVoyager Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : VYGR-US : September 13, 2016 (NASDAQ:VYGR)
www.capitalcube.com - September 14 at 12:25 PM
finance.yahoo.com logoVoyager Therapeutics and CHDI Foundation Collaborate to Develop Novel Gene Therapy for Huntington’s Disease (NASDAQ:VYGR)
finance.yahoo.com - September 13 at 6:52 AM
capitalcube.com logoETF’s with exposure to Voyager Therapeutics, Inc. : September 7, 2016 (NASDAQ:VYGR)
www.capitalcube.com - September 7 at 11:56 AM
capitalcube.com logoETF’s with exposure to Voyager Therapeutics, Inc. : August 26, 2016 (NASDAQ:VYGR)
www.capitalcube.com - August 26 at 11:03 AM
capitalcube.com logoVoyager Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : VYGR-US : August 25, 2016 (NASDAQ:VYGR)
www.capitalcube.com - August 25 at 8:27 PM
4-traders.com logoVoyager Therapeutics : to Attend Upcoming Investor Conferences (NASDAQ:VYGR)
www.4-traders.com - August 14 at 6:46 AM
publicnow.com logoVoyager Therapeutics to Attend Upcoming Investor Conferences (NASDAQ:VYGR)
www.publicnow.com - August 12 at 8:20 PM
sg.finance.yahoo.com logoVoyager Therapeutics reports 2Q loss (NASDAQ:VYGR)
sg.finance.yahoo.com - August 11 at 11:40 AM
biz.yahoo.com logoVOYAGER THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (NASDAQ:VYGR)
biz.yahoo.com - August 11 at 11:40 AM
publicnow.com logoVoyager Therapeutics Provides Second Quarter 2016 Investor Update (NASDAQ:VYGR)
www.publicnow.com - August 11 at 11:40 AM
publicnow.com logoVoyager Therapeutics Initiates Third Cohort in Ongoing Phase 1b Clinical Trial of VY-AADC01 in Advanced Parkinson’s Disease (NASDAQ:VYGR)
www.publicnow.com - August 9 at 11:41 AM
finance.yahoo.com logoWhy Earnings Season Could Be Great for Voyager Therapeutics (VYGR) (NASDAQ:VYGR)
finance.yahoo.com - August 9 at 11:41 AM
publicnow.com logoVoyager Therapeutics to Host Second Quarter 2016 Investor Update Call (NASDAQ:VYGR)
www.publicnow.com - August 4 at 11:29 AM
capitalcube.com logoETF’s with exposure to Voyager Therapeutics, Inc. : July 25, 2016 (NASDAQ:VYGR)
www.capitalcube.com - July 25 at 1:51 PM
capitalcube.com logoVoyager Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : VYGR-US : July 18, 2016 (NASDAQ:VYGR)
www.capitalcube.com - July 18 at 8:06 AM
breakingfinancenews.com logoVoyager Therapeutics Inc (NASDAQ:VYGR) stock price target upped to $33 as recorded today by Stifel Nicolaus (NASDAQ:VYGR)
breakingfinancenews.com - July 16 at 7:28 PM
capitalcube.com logoETF’s with exposure to Voyager Therapeutics, Inc. : July 7, 2016 (NASDAQ:VYGR)
www.capitalcube.com - July 7 at 3:08 PM
nasdaq.com logoVoyager Therapeutics Announces Interim Phase 1b Surgical Results for VY-AADC01 in Advanced Parkinson’s Disease (NASDAQ:VYGR)
www.nasdaq.com - June 22 at 8:06 PM
streetinsider.com logoVoyager Therapeutics (VYGR) Offers Interim Phase 1b Data on VY-AADC01 in PD Patients (NASDAQ:VYGR)
www.streetinsider.com - June 22 at 8:06 PM
finance.yahoo.com logoVoyager Therapeutics Reveals Interim Phase 1b Surgical Results For VY-AADC01 In Advanced Parkinson's Disease (NASDAQ:VYGR)
finance.yahoo.com - June 22 at 9:03 AM
biz.yahoo.com logoVOYAGER THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:VYGR)
biz.yahoo.com - June 16 at 4:50 PM
finance.yahoo.com logoVoyager (VYGR) Looks Good: Stock Adds 6.8% in Session (NASDAQ:VYGR)
finance.yahoo.com - May 31 at 8:00 AM
capitalcube.com logoVoyager Therapeutics, Inc. :VYGR-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 (NASDAQ:VYGR)
www.capitalcube.com - May 23 at 1:39 PM
kcregister.com logoHot Alert: ConocoPhillips (NYSE:COP), Voyager Therapeutics, Inc. (NASDAQ:VYGR), Nortek Inc. (NASDAQ:NTK ... - KC Register (NASDAQ:VYGR)
www.kcregister.com - May 23 at 10:40 AM
kcregister.com logoTop Wall Street Stories: Voyager Therapeutics, Inc. (NASDAQ:VYGR), New Gold, Inc. (NYSEMKT:NGD), NVIDIA ... - KC Register (NASDAQ:VYGR)
www.kcregister.com - May 21 at 10:44 AM
sg.finance.yahoo.com logoVoyager Therapeutics reports 1Q loss (NASDAQ:VYGR)
sg.finance.yahoo.com - May 12 at 7:17 AM
publicnow.com logoVoyager Therapeutics Provides First Quarter 2016 Investor Update (NASDAQ:VYGR)
www.publicnow.com - May 12 at 7:17 AM
biz.yahoo.com logoQ1 2016 Voyager Therapeutics Inc Earnings Release - Before Market Open (NASDAQ:VYGR)
biz.yahoo.com - May 12 at 7:07 AM
publicnow.com logoVoyager Therapeutics to Present at Upcoming Investor Conferences (NASDAQ:VYGR)
www.publicnow.com - May 11 at 8:52 AM
publicnow.com logoVoyager Therapeutics to Host First Quarter 2016 Investor Update Call (NASDAQ:VYGR)
www.publicnow.com - May 5 at 8:21 AM
thestreet.com logoVoyager Therapeutics Highlights Programs In Parkinson's Disease And ALS; Announces Expansion Of CNS Pipeline At R&D Day (NASDAQ:VYGR)
www.thestreet.com - April 29 at 9:58 AM
publicnow.com logoVoyager Therapeutics Highlights Programs in Parkinson’s Disease and ALS; Announces Expansion of CNS Pipeline at R&D Day (NASDAQ:VYGR)
www.publicnow.com - April 29 at 8:29 AM
finance.yahoo.com logoToday's Bell Ringer, April 26, 2016 (NASDAQ:VYGR)
finance.yahoo.com - April 26 at 9:16 AM
publicnow.com logoVoyager Therapeutics (Nasdaq: VYGR) to Ring The Nasdaq Stock Market Opening Bell (NASDAQ:VYGR)
www.publicnow.com - April 25 at 11:49 AM
News IconVoyager Therapeutics Incorporated (NASDAQ:VYGR) Short Interest Increased By 11.08% (NASDAQ:VYGR)
www.bibeypost.com - April 25 at 10:00 AM
fxpips.com logoBig Moving Stocks, April 14 – VYGR, PYDS, EMKR, GPRO, LSCC, RESN, CYBE, CONN, DMTX, ARGS (NASDAQ:VYGR)
www.fxpips.com - April 14 at 9:53 AM
publicnow.com logoVoyager Therapeutics to Host R&D Day and Webcast on April 29, 2016 (NASDAQ:VYGR)
www.publicnow.com - April 14 at 8:29 AM
fxpips.com logoBusiness Update: Wednesday Big Movers – LBTYB, HPJ, VYGR, CSTE, ASYS, CARV, CRBP, SBBP, TTNP (NASDAQ:VYGR)
www.fxpips.com - April 13 at 9:57 AM
finance.yahoo.com logoVoyager Therapeutics (VYGR) Jumps: Stock Rises 13.9% (NASDAQ:VYGR)
finance.yahoo.com - April 13 at 8:15 AM
finance.yahoo.com logoVOYAGER THERAPEUTICS, INC. Financials (NASDAQ:VYGR)
finance.yahoo.com - March 23 at 1:04 PM
finance.yahoo.com logoEdited Transcript of VYGR earnings conference call or presentation 17-Mar-16 12:30pm GMT (NASDAQ:VYGR)
finance.yahoo.com - March 17 at 1:13 PM
biz.yahoo.com logoVoyager Therapeutics Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:VYGR)
biz.yahoo.com - March 17 at 8:30 AM
sg.finance.yahoo.com logoVoyager Therapeutics reports 4Q loss (NASDAQ:VYGR)
sg.finance.yahoo.com - March 17 at 7:16 AM
biz.yahoo.com logoQ4 2015 Voyager Therapeutics Inc Earnings Release - Before Market Open (NASDAQ:VYGR)
biz.yahoo.com - March 17 at 7:07 AM
finance.yahoo.com logoVoyager Therapeutics Provides Fourth Quarter and Full Year 2015 Investor Update (NASDAQ:VYGR)
finance.yahoo.com - March 17 at 7:00 AM
thestreet.com logoVoyager Therapeutics To Present At Alliance For Regenerative Medicine's 4th Annual Cell & Gene Therapy Investor Day (NASDAQ:VYGR)
www.thestreet.com - March 14 at 9:18 AM
finance.yahoo.com logoVoyager Therapeutics to Present at Alliance for Regenerative Medicine’s 4th Annual Cell & Gene Therapy Investor Day (NASDAQ:VYGR)
finance.yahoo.com - March 14 at 8:00 AM

Social

Voyager Therapeutics (NASDAQ:VYGR) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff